Research by Khalaf et al. [24] has elucidated the connection between CTLA-4 polymorphisms and systemic lupus erythematosus (SLE) susceptibility, reinforcing the necessity of considering genetic backgrounds when evaluating risks for developing autoimmune diseases. The gene discussed is CTLA4; the disease is systemic lupus erythematosus.